Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol

Thavorn, Kednapa, Mamdani, Muhammad M, Straus, Sharon E·2014·Systematic Reviews
DOI 10.1186/2046-4053-3-71
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2046-4053-3-71

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 33

  1. Ruhl C, Sayer B, Byrd-Holt D, Brown D: The burden of digestive diseases in the United States. Costs of Digestive Diseases. Edited by: Everhart JE. 2009, Bethesda: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  2. Lewison G: Gastroenterology in the UK: the Burden of Disease. 1997, London: The Wellcome Trust
  3. Tillisch K: Complementary and alternative medicine for functional gastrointestinal disorders. Gut. 2006, 55: 593-596. 10.1136/gut.2005.078089. · DOI
  4. Devesa Jorda F, Pellicer Bataller J, Ferrando Ginestar J, Borghol Hariri A, Bustamante Balen M, Ortuno Cortes J, Ferrando Marrades I, Llobera Bertran C, Sala Lajo A, Minana Morell M, Nolasco Bonmatí A, Fresquet Febrer JL: Consumption of medicinal herbs in patients attending a gastroenterology outpatient clinic. Gastroenterol Hepatol. 2004, 27: 244-249. 10.1016/S0210-5705(03)70453-1. · DOI
  5. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med. 1991, 57: 1-7. 10.1055/s-2006-960004. · DOI · Paper page
  6. Jurenka JS: Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009, 14: 141-153.
  7. Sharma OP: Antioxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976, 25: 1811-1812. 10.1016/0006-2952(76)90421-4. · DOI · Paper page
  8. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK: Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999, 47: 4297-4300. 10.1021/jf990308d. · DOI
  9. Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH: Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol. 1999, 58: 1167-1172. 10.1016/S0006-2952(99)00206-3. · DOI
  10. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB: Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008, 267: 133-164. 10.1016/j.canlet.2008.03.025. · DOI
  11. Mills S, Bone K: Principles and Practice of Phytotherapy. 2000, London: Churchill Livingstone
  12. Rafatullah S, Tariq M, Al-Yahya MA, Mossa JS, Ageel AM: Evaluation of turmeric (Curcuma longa) for gastric and duodenal antiulcer activity in rats. J Ethnopharmacol. 1990, 29: 25-34. 10.1016/0378-8741(90)90094-A. · DOI
  13. Thamlikitkul V, Bunyapraphatsara N, Dechatiwongse T, Theerapong S, Chantrakul C, Thanaveerasuwan T, Nimitnon S, Boonroj P, Punkrut W, Gingsungneon V, Wongkonkatape S, Ekpalakorn W, Boontaeng N, Jesadaporn U, Taechaiya S, Petcharoen S, Riewpaiboon A, Adthasit R, Timsard S, Tenambergen ED: Randomized double blind study of Curcuma domestica Val. for dyspepsia. J Med Assoc Thai. 1989, 72: 613-620.
  14. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, Koide Y: Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006, 4: 1502-1506. 10.1016/j.cgh.2006.08.008. · DOI · Paper page
  15. Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stutzer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG: Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial. Scand J Gastroenterol. 2005, 40: 936-943. 10.1080/00365520510023134. · DOI · Paper page
  16. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, Henry DA, Boers M: AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009, 62: 1013-1020. 10.1016/j.jclinepi.2008.10.009. · DOI · Paper page
  17. Kumar S, Ahuja V, Sankar MJ, Kumar A, Moss AC: Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012, 10: Cd008424-
  18. Tack J, Bisschops R, Sarnelli G: Pathophysiology and treatment of functional dyspepsia. Gastroenterology. 2004, 127: 1239-1255. 10.1053/j.gastro.2004.05.030. · DOI
  19. American International Health Alliance: Protocol for diagnosis and treatment of peptic ulcer in adults. 2002, Washington: American International Health Alliance
  20. DeVault KR, Castell DO: Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005, 100: 190-200. 10.1111/j.1572-0241.2005.41217.x. · DOI · Paper page
  21. Gwee KA, Teng L, Wong RK, Ho KY, Sutedja DS, Yeoh KG: The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2009, 21: 417-424. 10.1097/MEG.0b013e328317b89e. · DOI
  22. Veldhuyzen van Zanten SJ: The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1997, 11 (Suppl 1): 63-69. · DOI
  23. Revicki DA, Rentz AM, Tack J, Stanghellini V, Talley NJ, Kahrilas P, De La Loge C, Trudeau E, Dubois D: Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders. Clin Gastroenterol Hepatol. 2004, 2: 769-777. 10.1016/S1542-3565(04)00348-9. · DOI
  24. Bamberg P, Caswell CM, Frame MH, Lam SK, Wong EC: A meta-analysis comparing the efficacy of omeprazole with H2-receptor antagonists for acute treatment of duodenal ulcer in Asian patients. J Gastroenterol Hepatol. 1992, 7: 577-585. 10.1111/j.1440-1746.1992.tb01489.x. · DOI
  25. Romano M, Cuomo A: Eradication of Helicobacter pylori: a clinical update. Med Gen Med. 2004, 6: 19-
  26. Akehurst R, Kaltenthaler E: Treatment of irritable bowel syndrome: a review of randomised controlled trials. Gut. 2001, 48: 272-282. 10.1136/gut.48.2.272. · DOI
  27. Drossman DA, Li Z, Toner BB, Diamant NE, Creed FH, Thompson D, Read NW, Babbs C, Barreiro M, Bank L, Whitehead WE, Schuster MM, Guthrie EA: Functional bowel disorders: a multicenter comparison of health status and development of illness severity index. Dig Dis Sci. 1995, 40: 986-995. 10.1007/BF02064187. · DOI
  28. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A: Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther. 2003, 17 (Suppl 2): 11-17. · DOI
  29. Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF: Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005, 353: 2462-2476. 10.1056/NEJMoa050516. · DOI
  30. Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP: Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Am J Gastroenterol. 2009, 104: 1452-1459. 10.1038/ajg.2009.83. · DOI
  31. Allen CJ, Parameswaran K, Belda J, Anvari M: Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus. 2000, 13: 265-270. 10.1046/j.1442-2050.2000.00129.x. · DOI
  32. Williford WO, Krol WF, Spechler SJ: Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial: VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). Control Clin Trials. 1994, 15: 335-348. 10.1016/0197-2456(94)90031-0. · DOI
  33. Chemoprevention Branch and Agent Development Committee: Clinical development plan: Curcumin. J Cell Biochem. 1996, 63: 72-85. · DOI

Cited by

See all 20

Metadata

Authors
Thavorn, K., Mamdani, M. M., & Straus, S. E.
Venue
Systematic Reviews
Publisher
Springer Science and Business Media LLC
Published
2014-06-28
Volume
3
Issue
1
ISSN
2046-4053
DOI
10.1186/2046-4053-3-71
Cited by
20
References
2
Language
en
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol. https://app.cochat.ai/papers/10.1186/2046-4053-3-71
The paper
Thavorn, K., Mamdani, M. M., & Straus, S. E. (2014). Efficacy of turmeric in the treatment of digestive disorders: a systematic review and meta-analysis protocol. Systematic Reviews. https://doi.org/10.1186/2046-4053-3-71

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.